Gemini Therapeutics logo
Gemini Therapeutics GMTX
$ 1.56 0.97%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Gemini Therapeutics Long Term Debt Current 2011-2024 | GMTX

Annual Long Term Debt Current Gemini Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
665 K 307 K 319 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
665 K 307 K 430 K